NORTH CAROLINA CENTRAL UNIVERSITY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
C07D HETEROCYCLIC COMPOUNDS 4158
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3122
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 2136
 
  
 
C07K PEPTIDES 1135
 
  
 
C08F MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 1124
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205
 
  
 
G01Q SCANNING-PROBE TECHNIQUES OR APPARATUS; APPLICATIONS OF SCANNING-PROBE TECHNIQUES, e.g. SCANNING-PROBE MICROSCOPY [SPM]117

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0333,356 Treatment Method and Product for Uterine Fibroids using Purified CollagenaseAug 01, 17Nov 23, 17[A61K]
2016/0237,058 PHENOXY THIOPHENE SULFONAMIDES AND OTHER COMPOUNDS FOR USE AS INHIBITORS OF BACTERIAL GLUCURONIDASEMar 03, 16Aug 18, 16[C12Q, C07D]
2015/0119,325 METHODS FOR THE PRODUCTION OF CYTOPROTECTIVE ASIALO-ERYTHROPOIETIN IN PLANTS AND ITS PURIFICATION FROM PLANT TISSUESMar 14, 13Apr 30, 15[C12N, C07K]
2013/0323,734 Genetic Determinants of Prostate Cancer RiskMay 31, 13Dec 05, 13[C12Q]
2013/0217,789 BIODEGRADABLE LIQUOGEL AND PH SENSITIVE NANOCARRIERSSep 02, 11Aug 22, 13[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9879324 Genetic determinants of prostate and breast cancer riskMar 30, 12Jan 30, 18[C12Q]
9863002 Genetic determinants of prostate cancer riskMay 31, 13Jan 09, 18[C12Q, C12P]
9744138 Treatment method and product for uterine fibroids using purified collagenaseMar 14, 14Aug 29, 17[A61K]
9617239 Phenoxy thiophene sulfonamides and their use as inhibitors of glucuronidaseMar 10, 11Apr 11, 17[A61K, C12Q, C07D]
8060943 Carbon nanotube oscillator surface profiling device and method of useAug 26, 09Nov 15, 11[G01Q]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0176,859 High-Throughput Assay for Identifying Small Molecules that Modulate AMP-activated Protein Kinase (AMPK)AbandonedFeb 10, 16Jun 23, 16[C07D, G01N]
2013/0345,196 PHENOXY THIOPHENE SULFONAMIDES AND OTHER COMPOUNDS FOR USE AS INHIBITORS OF BACTERIAL GLUCURONIDASEAbandonedMay 24, 12Dec 26, 13[A61K, C07D]
8557808 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agentsExpiredDec 09, 10Oct 15, 13[A61K, C07D]
2013/0195,815 METHOD FOR LABELING INSULIN-SECRETING PANCREATIC BETA CELLS AND OBTAINING PURIFIED INSULIN-SECRETING PANCREATIC B-CELLS AND AN INSULIN REPORTEDAbandonedOct 12, 12Aug 01, 13[A61K, C12Q]
2007/0244,200 Method for triggering angiogenic responseAbandonedApr 15, 06Oct 18, 07[A61K]
5192761 1,2,4-triazolidine-3,5-diones and 1,3,5-triazine-2,4(1-H,3H)-diones, pharmaceutical compositionsExpiredNov 06, 90Mar 09, 93[A61K]
5034528 Compositions for the control of hyperlipidemiaExpiredJul 27, 88Jul 23, 91[A61K, C07D]
4999366 Isoxazolidine-3,5-diones, pharmaceutical compositions and method of treatmentExpiredMar 12, 90Mar 12, 91[C07C]
4946963 Compounds for the control of hyperlipidemia using N-substituted isoxazolidine-3,5-dionesExpiredOct 31, 88Aug 07, 90[C07C]
4494547 2H-isoindolediones, their synthesis and use as radiosensitizersExpiredMar 30, 81Jan 22, 85[A61K, A61N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.